pf-3246799 and Urinary-Incontinence--Stress

pf-3246799 has been researched along with Urinary-Incontinence--Stress* in 1 studies

Other Studies

1 other study(ies) available for pf-3246799 and Urinary-Incontinence--Stress

ArticleYear
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.
    Journal of medicinal chemistry, 2014, Jun-26, Volume: 57, Issue:12

    A series of 4-substituted pyrimido[4,5-d]azepines that are potent, selective 5-HT2C receptor partial agonists is described. A rational medicinal chemistry design strategy to deliver CNS penetration coupled with SAR-based optimization of selectivity and agonist potency provided compounds with the desired balance of preclinical properties. Lead compounds 17 (PF-4479745) and 18 (PF-4522654) displayed robust pharmacology in a preclinical canine model of stress urinary incontinence (SUI) and no measurable functional agonism at the key selectivity targets 5-HT2A and 5-HT2B in relevant tissue-based assay systems. Utilizing recent advances in the structural biology of GPCRs, homology modeling has been carried out to rationalize binding and agonist efficacy of these compounds.

    Topics: Animals; Azepines; Blood-Brain Barrier; Central Nervous System Agents; CHO Cells; Cricetulus; Dogs; Drug Design; Humans; Madin Darby Canine Kidney Cells; Permeability; Pyrimidines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Urinary Incontinence, Stress

2014